Market Tracker

07/26 12:44pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

3.68
Delayed Data
As of 12:19pm ET
 -0.025 / -0.68%
Today’s Change
2.35
Today|||52-Week Range
4.49
+50.00%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.70
Today’s open3.70
Day’s range3.65 - 3.75
Volume14,680
Average volume (3 months)202,857
Market cap$203.6M
Dividend yield--
Data as of 12:19pm ET, 07/26/2017

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+78.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratio--
Price/Sales87.21
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.17-3.78%
FOMXFoamix Pharmaceutica...-0.05-0.93%
KURAKura Oncology Inc+0.20+2.15%
URGNUrogen Pharma Ltd+0.01+0.05%
Data as of 12:44pm ET, 07/26/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts